Anastasia Ryapolova

5PUBLICATIONS
12CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2026
Assessment of the Novel rVSV-PD-1-4-1BBL Oncolytic Activity on Mouse and Human Cancer Cell Lines.

|Dec 11, 2025
Interferon-Based Therapeutics in Cancer Therapy: Past, Present, and Future.

Kristina Vorona, Anastasia Ryapolova, Olesya Sokolova

|Sep 13, 2025
Recombinant Oncolytic Vesicular Stomatitis Virus Expressing Mouse Interleukin-12 and Granulocyte-Macrophage Colony-Stimulating Factor (rVSV-dM51-mIL12-mGMCSF) for Immunotherapy of Lung Carcinoma.

Anastasia Ryapolova, Margarita Zinovieva, Kristina Vorona

|Jun 26, 2025
Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine.

Egor Panferov, Maria Dodina, Vasiliy Reshetnikov

|Jan 11, 2024
Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy.

Anastasia Ryapolova, Ekaterina Minskaia, Nizami Gasanov

Pageof 1

Frequent Collaborators

5 joint publications

Ekaterina Minskaia

5 joint publications

Roman Ivanov

5 joint publications

Alexander Karabelsky

2 joint publications

Nizami Gasanov